Skip to main content
Premium Trial:

Request an Annual Quote

BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies: Nov 25, 2004

 

Bruker Insider Buy Bolsters 17-Percent Weekly Gain; Index Climbs

Bruker BioScience’s share price closed a shortened coverage period for the BioCommerce Week Index on Monday at $4.33, a 17-percent gain based largely on an insider purchase of 200,000 shares by CEO Frank Laukien last week.

Bruker’s gain offset share-price losses by seven of the 15 select molecular biology companies tracked in the index in the four-day period ending Monday. The usual five-day tracking period for the index was shortened due to early Thanksgiving holiday publishing deadlines.

Bio-Rad followed Bruker’s gain with a 5-percent improvement on the week, closing at $55.66, up from $53.68 last week as investors apparently responded to the as-yet unverified possibility of another US case of mad cow disease. (See story, page 1).

Other gainers on the week included Applied Biosystems, closing at $20.57, up 3 percent from last week’s $20.00 close; and Beckman Coulter, closing at $63.74, up 2 percent over last week’s $62.68. Sigma also closed up at $58.68, a 1-percent increase over last week’s $57.88, followed by Waters, closing at $46.41, up from $45.85 last week.

Agilent and BD each were up a fraction of a percent. Agilent closed at $23.08, up from $22.95. BD closed at $54.72, up from $54.53 last week.

PerkinElmer led the week’s losers with a 5 percent drop, closing Monday at $20.80, down from $21.80 last week. Stratagene dropped to $6.80 from last week’s $6.92, marking a third straight weekly loss for the La Jolla, Calif.-based reagent marketer. Invitrogen closed at $61.54, from from $61.88 last week.

Overall, the index closed at $33.92, up 1 percent over last week’s $33.57 close and marking a fourth consecutive week of gains.

For the week, the index outperformed all of the large indexes as the Nasdaq, S&P 500, and the Dow all fell a fraction of a percent. Meantime, the Amex Biotech index dropped just under 2 percent while the Amex Pharma Index dropped approximately 2.5 percent.

File Attachments
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.